Introduced to the market in the 1990s, Elmiron was the first FDA-approved drug to treat interstitial cystitis. Interstitial cystitis (IC) is a bladder condition without a cure and is noted to be very painful. Elmiron was marketed to eliminate the symptoms of IC, including painful bladder, the urge to urinate frequently, and pelvic pain.
Elmiron was manufactured by a corporate subsidiary of Johnson & Johnson, Jansen Pharmaceuticals Inc. In 1996, Elmiron received approval from the FDA and since received growing recommendations for treatment options with those with IC. While many have heard of Elmiron, it is important to note it is the brand name for the drug pentosan polysulfate sodium.
The Effects of Using Elmiron
In 2018 the harmful effects of Elmiron began to be noted by doctors. As an increase in patients with maculopathy and a common factor of the use of Elmiron, the suggested harmful effects of the use of Elmiron were reported. As more testing and reporting began to take place, toxicity of Elmiron and correlation to maculopathy and or severe eye damage became apparent.
1 in 4
It is estimated that 1 in 4 patients who used the drug Elmiron may develop maculopathy. If you were prescribed Elmiron and took the drug daily for 6-months or longer and experienced or were diagnosed with any of the following conditions, you may deserve compensation:
- Retinal dystrophy
- Age-related macular degeneration
- Other retinal damage conditions
Call For Your Free Consultation
If you have been diagnosed with maculopathy or other eye conditions and used the drug Elmiron, you may be entitled to compensation. It is important to act fast and have your case reviewed by an injury attorney like all legal cases. Campbell & Associates has been representing clients in pharmaceutical cases for over 30 years. Our team of experienced attorneys are ready to hear your story. We’ll review your case, listen to your concerns, and advise you if we think you have a solid case. You’ll only pay if your case is won. Call 704-333-0885 to request your free consultation with Campbell & Associates.
*The contingency percentage attorney’s fee will be taken from the total recovery before costs and expenses are paid or reimbursed.